Lexeo Therapeutics, Inc. (LXEO) Gains from Investment Securities (2022 - 2023)
Lexeo Therapeutics' Gains from Investment Securities history spans 2 years, with the latest figure at $105000.0 for Q4 2023.
- For Q4 2023, Gains from Investment Securities fell 2.78% year-over-year to $105000.0; the TTM value through Dec 2023 reached $425000.0, changed N/A, while the annual FY2024 figure was $410000.0, 3.53% down from the prior year.
- Gains from Investment Securities for Q4 2023 was $105000.0 at Lexeo Therapeutics, down from $107000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $110000.0 in Q1 2023 and bottomed at $103000.0 in Q2 2023.